Mangoceuticals, Inc. Common Stock
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also p… Read more
Mangoceuticals, Inc. Common Stock (MGRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.079x
Based on the latest financial reports, Mangoceuticals, Inc. Common Stock (MGRX) has a cash flow conversion efficiency ratio of -0.079x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.24 Million) by net assets ($15.73 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mangoceuticals, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Mangoceuticals, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Mangoceuticals, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mangoceuticals, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RENDER CUBE BSAC ZY -10
F:W63
|
N/A |
|
Keynote Financial Services Limited
NSE:KEYFINSERV
|
-0.046x |
|
Citra Nusantara Gemilang Tbk.
JK:CGAS
|
0.047x |
|
ROCHE HLDG - Dusseldorf Stock Exchang
DU:RHO
|
N/A |
|
Epsium Enterprise Limited Ordinary Shares
NASDAQ:EPSM
|
N/A |
|
Yong Concrete PCL
BK:YONG
|
0.033x |
|
Shrinkflex (Thailand) Public Company Limited
BK:SFT
|
0.064x |
|
Fenbo Holdings Limited Ordinary Shares
NASDAQ:FEBO
|
0.027x |
Annual Cash Flow Conversion Efficiency for Mangoceuticals, Inc. Common Stock (2021–2024)
The table below shows the annual cash flow conversion efficiency of Mangoceuticals, Inc. Common Stock from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $13.95 Million | $-4.86 Million | -0.349x | +96.14% |
| 2023-12-31 | $774.75K | $-7.00 Million | -9.032x | -311.86% |
| 2022-12-31 | $614.03K | $-1.35 Million | -2.193x | -309.28% |
| 2021-12-31 | $-16.72K | $-17.52K | 1.048x | -- |